Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Paediatric Neuroimaging researcher provides real-time case information on epidemiological data from the COVID-19 outbreak.

A visualisation showing a map with number of COVID-19 cases around the world

Maria Cobo, a DPhil student with the Paediatric Neuroimaging Group, is part of the Open COVID-19 Data Working Group, a response project coordinated by the Department of Zoology and the Oxford Martin School. It is an international team of volunteers curating data sources by hand and compiling the data in a standardised format. Uniquely, this format presents epidemiological data at an individual case level, which allows the extraction of detailed information on case demographics, travel histories and high resolution geographical distribution.

The cumulative results are updated daily, and can be viewed here: https://www.healthmap.org/covid-19/

Data fuelling the project are openly accessible here: https://github.com/beoutbreakprepared/nCoV2019/tree/master/latest_data

The description of the database and methods used was recently published in Scientific Data.

If you would like to take part in the project, please get in touch with Maria Cobo.

 

Funding for Oxford’s COVID-19 research requires unprecedented speed, scope and ambition. If you would like to support this work, please make a gift  >>

Similar stories

Fourth COVID-19 vaccine dose provides stronger immunity boost than third dose, shows UK study

COVID-19 vaccines given as fourth doses in the UK offer excellent boosting immunity protection, according to the latest results from a nationwide NIHR-supported study.

Oxford scientist named Australian of the Year in the UK

The Oxford Vaccine Group’s Lead Statistician, Professor Merryn Voysey, received the prestigious Australian of the Year in the UK award at a gala dinner recently.

Angelman syndrome: first patient to receive potential therapy in Oxford

Things that seemed impossible, only a few years ago, are happening today. The first patient in Europe and one of the first in the world was injected with a potential treatment, GTX-102, in a phase I/II clinical trial in Oxford.

New model for infant leukaemia announced

The breakthrough could lead to development of new treatments for infant Acute Lymphoblastic Leukaemia.

Why it's so hard to treat pain in infants

For decades physicians believed that premature babies didn’t experience pain. Here’s what doctors know now – and the innovative solutions being embraced by today's caregivers.

Oxford to work with Brazil to establish clinical research hub

The University of Oxford and Brazilian Ministry of Health have announced a joint initiative to set up a global health and clinical research unit in Brazil led by Professor Sue Ann Clemens CBE.